Science Explorer Back to mapMap
Discussion
Researcher · Euskadiko Parke Teknologikoa · Spain

Cristina Alonso

Cristina Alonso publishes mostly in Molecular Biology, Epidemiology and Endocrinology, Diabetes and Metabolism, on topics such as Liver Disease Diagnosis and Treatment, Metabolomics and Mass Spectrometry Studies and Diet, Metabolism, and Disease.

ORCID 0000-0002-2019-678X OpenAlex
World rank
#362,297
of 7,710,434 ranked researchers
Rank in Spain
#6,301
of 204,306
Works
163
Citations
5.9k
Citations per work
36.4
h-index
42
i10-index 78Top 6.3% in Molecular Biology
Cristina Alonso

What does Cristina Alonso research?

Cristina Alonso's work is mostly in Medicine (33%), Biochemistry, Genetics and Molecular Biology (22%).

Everything else: 74 works · 45.6% of their workHealth Sciences: 53 works · 32.8% of their workMedicine: 53 works · 32.8% of their workEpidemiology: 26 works · 16.2% of their workEndocrinology, Diabetes and Metabolism: 12 works · 7.4% of their workHepatology: 9 works · 5.6% of their workPhysiology: 6 works · 3.6% of their workLife Sciences: 35 works · 21.6% of their workBiochemistry, Genetics and Molecular Biology: 35 works · 21.6% of their workMolecular Biology: 28 works · 17.3% of their workCancer Research: 7 works · 4.3% of their workTHEIR WORKCristina Alonso163works
Life Sciences22%Health Sciences33%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else7445.6%
    1. Medicine5332.8%
    1. Biochemistry, Genetics and Molecular Biology3521.6%
  1. 1Molecular Biology17% of their works
  2. 2Epidemiology16% of their works
  3. 3Endocrinology, Diabetes and Metabolism7% of their works
  4. 4Hepatology6% of their works
  5. 5Cancer Research4% of their works
  6. 6Physiology4% of their works

Research topics

Which keywords describe Cristina Alonso's research?

The keywords of their largest research topics: Insulin Resistance, Metabolic Syndrome, NAFLD, NASH, Mass Spectrometry, Metabolomics, Cholesterol and Fructose.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Insulin Resistance872 topics
  2. Metabolic Syndrome872 topics
  3. NAFLD681 topic
  4. NASH681 topic
  5. Mass Spectrometry311 topic
  6. Metabolomics311 topic
  7. Cholesterol202 topics
  8. Fructose191 topic
  9. Obesity191 topic
  10. Chiral Separation121 topic
  11. Liquid Chromatography121 topic
  12. Fatty Acid Synthase111 topic
  13. Lipid Metabolism111 topic
  14. Counter-Current Chromatography91 topic
  15. Lab-on-a-Chip91 topic
  16. Lipid Rafts91 topic
  17. Membrane Lipids91 topic
  18. Natural Product Isolation91 topic
  19. Poly(dimethylsiloxane)91 topic

Where does Cristina Alonso work?

Cristina Alonso's main affiliation in the publication record is Euskadiko Parke Teknologikoa, Spain.

How many publications and citations does Cristina Alonso have?

OpenAlex counts 163 works and 5,937 citations for Cristina Alonso, an h-index of 42, ranking #362,297 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Cristina Alonso

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Cristina Alonso. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.